22157.jpg
UK Patient's Perspective on the Corporate Reputation of Pharma, 2023-2024
August 20, 2024 11:52 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Survey of 314 US Patient Groups Reveals Decline in Pharma Industry Reputation in 2023/2024
August 20, 2024 10:31 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups" report has been added to...
22157.jpg
Corporate Reputation of Pharma in Canada, 2023/2024: The Views of 100 Canadian Patient Groups - Fair Pricing Policies, Transparency of Pricing, and Engaging Patients in R&D Among the Lowest-Scoring Indicators
June 26, 2024 09:25 ET | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups" report has been...
22157.jpg
Corporate Reputation of Pharma in 2023/2024: The Patient Perspective and Views of 2,500+ Patient Groups - Pharma Corporate Reputation Falls from COVID Highs
June 26, 2024 06:51 ET | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide" report has...
22157.jpg
Patient Perspective of 520 Cancer Patient Groups on the Corporate Reputation of Pharma in 2023/2024: Roche Ranked 1st, AstraZeneca Ranked 2nd, and Pfizer Ranked 3rd
June 21, 2024 08:54 ET | Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been...
Chart 5 The Pharma Companies Rising the Most in the Italy Rankings, 2020 to 2021
The Views of 103 Italian Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Roche Ranked 1st Overall with Novo Nordisk in 2nd and Pfizer in 3rd
January 12, 2023 08:53 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups" report has been added to...
22157.jpg
Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Ranking of 24 Companies
January 12, 2023 06:38 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups" report has been added...
Neurology Company Pharma Rankings
Views of 258 Neurology Patient Groups on the Corporate Reputation of Pharma in 2022: Roche Ranked 1st, Novartis Ranked 2nd and Biogen Ranked 3rd
January 12, 2023 06:28 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups" report has been...
22157.jpg
The Views of 300 Asian Patient Groups on the he Corporate Reputation of Pharma, 2021-2022: Overall Gilead Sciences Ranked 1st, Pfizer Ranked 2nd, and ViiV Healthcare Ranked 3rd
January 12, 2023 06:23 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups" report has been added to ...
France Pharma Company Rankings
The Views of 109 French Patient Groups on the Corporate Reputation of Pharma in 2021-2022: Amgen, Mylan, Eli Lilly, MSD, and Boehringer Ingelheim Witnessed the Biggest Rise in Rankings
January 12, 2023 06:18 ET | Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups" report has been added to...